-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Lje5fee5JarZvF2r4Erd4lgEixZexYsrDCLtV2LVOIWM+5a9s7UE+6GxSACybbqA
 Q0JIUa+84vIamUhK8igyig==

<SEC-DOCUMENT>0001193125-11-014843.txt : 20110126
<SEC-HEADER>0001193125-11-014843.hdr.sgml : 20110126
<ACCEPTANCE-DATETIME>20110126161333
ACCESSION NUMBER:		0001193125-11-014843
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20110121
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20110126
DATE AS OF CHANGE:		20110126

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARCA biopharma, Inc.
		CENTRAL INDEX KEY:			0000907654
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				363855489
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-22873
		FILM NUMBER:		11549587

	BUSINESS ADDRESS:	
		STREET 1:		8001 ARISTA PLACE
		STREET 2:		SUITE 200
		CITY:			BROOMFIELD
		STATE:			CO
		ZIP:			80021
		BUSINESS PHONE:		720-940-2200

	MAIL ADDRESS:	
		STREET 1:		8001 ARISTA PLACE
		STREET 2:		SUITE 200
		CITY:			BROOMFIELD
		STATE:			CO
		ZIP:			80021

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUVELO INC
		DATE OF NAME CHANGE:	20030203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HYSEQ INC
		DATE OF NAME CHANGE:	19970610
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:4px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>WASHINGTON, D.C. 20549 </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>FORM 8-K
</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Pursuant to Section&nbsp;13 or 15(d) of the </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Securities Exchange Act of
1934 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Date of Report (Date of Earliest Event Reported): January&nbsp;21, 2011 </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="6"><B>ARCA biopharma, Inc. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(Exact Name of Registrant as Specified in Charter) </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>000-22873</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>36-3855489</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(State or Other Jurisdiction</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>of Incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Commission</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>File Number)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(I.R.S. Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Identification No.)</B></FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8001 Arista Place, Suite 200,
Broomfield, CO 80021 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Address of Principal Executive Offices) (Zip Code) </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(720) 940-2200 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(Registrant&#146;s Telephone Number, Including Area Code) </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Not
Applicable </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Former Name or Former Address, if Changed Since Last Report) </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.
below): </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;1.01</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Entry into a Material Definitive Agreement </B></FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On January&nbsp;21, 2011, ARCA biopharma, Inc. (&#147;ARCA&#148;) and the University of Cincinnati agreed to extend the term of the Exclusive Option
Agreement dated December&nbsp;2, 2009 (filed as Exhibit 10.27 to the Company&#146;s Annual Report on Form 10-K for the period ended December&nbsp;31, 2009), as amended, that gave ARCA an option to license exclusive, worldwide rights to certain
patent rights relating to genetic polymorphisms of adrenergic cardiac receptors.&nbsp;The rights include those for developing and commercializing diagnostics for the receptor polymorphisms that may indicate which patients will respond most favorably
to Gencaro. The period of the option has been extended to March&nbsp;31, 2011.</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The letter in regard to the agreement term extension is filed
as Exhibit 10.1 to the Current Report on Form 8-K, and the description of the extension is qualified in its entirety by reference to such exhibit. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;9.01</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Financial Statements and Exhibits </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(d) Exhibits </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="91%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:39pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit&nbsp;No.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Letter in regard to agreement term extension, signed January&nbsp;21, 2011, of the Exclusive Option Agreement dated December&nbsp;2, 2009, as amended, between ARCA biopharma,
Inc. and the University of Cincinnati.</FONT></TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dated: January&nbsp;26, 2011 </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0">

<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ARCA biopharma, Inc.</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(Registrant)</FONT></P></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Christopher D. Ozeroff</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Name: Christopher D. Ozeroff</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Title: Senior Vice President and General Counsel</FONT></TD></TR></TABLE></DIV>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>EXHIBIT INDEX </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="91%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:39pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit&nbsp;No.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Letter in regard to agreement term extension, signed January&nbsp;21, 2011, of the Exclusive Option Agreement dated December&nbsp;2, 2009, as amended, between ARCA biopharma,
Inc. and the University of Cincinnati.</FONT></TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>dex101.htm
<DESCRIPTION>LETTER IN REGARD TO AGREEMENT TERM EXTENSION
<TEXT>
<HTML><HEAD>
<TITLE>Letter in regard to agreement term extension</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit 10.1 </B></FONT></P>
 <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center">

<IMG SRC="g144078g74x28.jpg" ALT="LOGO"> </P>
 <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>8001 Arista Place, Suite 200 </I></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Broomfield, CO 80021 </I></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Phone: 720-940-2200, Fax: 720-208-9261
</I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">January&nbsp;20, 2011 </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Geoffrey Pinski </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director of Intellectual Property </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">University of Cincinnati </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Office of Intellectual
Property </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">51 Goodman Dr, Suite 240 </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cincinnati, Ohio 45219-0829 </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dear Geoffrey,
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">When countersigned by the University of Cincinnati, this letter will extend the Exclusive Option Agreement between ARCA
biopharma, Inc. and the University of Cincinnati dated December&nbsp;2, 2009 to March&nbsp;31, 2011. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Please sign below
indicating your agreement to the above. Feel free to contact me if you have any questions. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0">

<TR>
<TD WIDTH="100%"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Best regards,</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Christopher D. Ozeroff</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christopher D. Ozeroff</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">SVP and General Counsel</FONT></TD></TR></TABLE></DIV> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0">

<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>ACCEPTED AND AGREED</U>:</FONT></TD></TR>
<TR>
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">UNIVERSITY OF CINCINNATI</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Geoffrey Pinski</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geoffrey Pinski</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">January 21, 2011</FONT></P></TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g144078g74x28.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g144078g74x28.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`:`$8`P$1``(1`0,1`?_$`,(```$$`@,!`0``````
M```````'"`D*!08!`PL"!`$!```'`0$!``````````````$#!`4&!P@)`@H0
M```&`0($`@<%!@0#!@<```$"`P0%!@<`$2$2$P@Q"4&AT2)2%!5188$R(W%"
MLC,6"I&Q)!?P<B7!X28G-W?Q8D,T1+4X$0`!`P,"`P4#!PH$!P```````0(#
M$00%(08Q$@=!42(3"&%Q,O"!D:%"TA2QP=%2(S.S%18)8E,D5/&B8W,T1";_
MV@`,`P$``A$#$0`_`+XMXO%?Q[7I.TVJ22B8.*2!5R[5$#"8QN4J#9!$`%5R
M[=K&Y$TB`)C&^P-8CO;>^W^GFWI]U;IG;!A;=OB7BY57@B)VJO!$^<K<?87&
M1N4M;5%?,]:(B=GR]I%GD?O]R#*R+AKC>,CJQ"IF42;OY-FC-3SL`,)2NE$%
M?^FL0,7B!.580#@([Z\H.I_]P_=V6R4]ETOMTL,2QRLBN)(XY))'I]I63-<B
M-I2E&I4WY@^C]C;VK+K-/\^5_P!A'*U&]M5Y:+]8ES7N[[F'A1Z=^2#8AC"(
M5:JB;8@;G'E^B@.Q`\>'#6CV^M'U3W,3VVF?C6=B*JTL;!:(G93\,92SIELE
MK%=):5I_U9?OF52[J>Y=0$O_`#`WW4Z9Q+5JD``([A[W/"\-C[!P](ZGQ^LC
MU47LZPVN?H[F:W_P+!>->^V*6?IQLN-/,;:_L_\`NR_?/UO.Z'N8:N73;^OA
M`R"ZR'&J54=C$4,0`$0A-A'<-5E_ZP/518Y.>SES_P"Z<YE/P%A\35I_MOJ)
M;-A[#5B*MIK3_-E^^8-UW<=S#=)-92^D(0Y3@0`JM5$3]$YDE#\841#]0HA^
MT-6QWK2]3L4;67&Y.2Z75*V&/HJ5[?\`2Z?436[`V*].1EBKG+V^;-I_SFYT
M;OXRY!/4`N[2&NL0)RBY!)DV@)M-`.!Q:N&92QRRP".X%.B`&\-P\0VCL+^X
M/U7P]_!;[]AM,GB^=/-E8R*.5&]M&Q(Q/?X=$+3E.C^-NK=S\16&X[$YW.3Y
M^957ZR4?&65:MEFK-;94GYEV2YC-G+1R0B,C&/TR`99C)-=N9NX3WW#B)3DV
M,41`=>KG2_JOM;JWMA-U;2F;+9<R)*U53GAT2J*G'OI5%KV&@\[@\AM^^=C<
M@Q62)P?V*G8J=GZ!1NJI\7J#V:VA[N!:`ZJGQ>HOLT`=53XO47V:`.J<>',/
M'[`#?\/='CH#09/*]`AK[6\4RUVJT?DRXP\U8*K1G4NU0LUC@J\<"SDO#1"B
M@.W;&*$X=8Y2FY0*([<!T!OW5/L`\W`0`0'8.("&X#Q*`\0T`=53XO47V:`.
MJ?XO47V:`P9[;7$WBD>I9J^G((J=%5BI,Q9'B2P%`XI*M3.0735`@@/*)0';
M0&2+*-#$%0LBQ,F&VZA7;02!OX;F!3EXZ`QKJX5>/'ED;37&)QYA`KR;BFP[
M%X&'99T0=BCX_9H#]<=/1<P43Q$Q%RI2@(B:,D&+\``!Y1$1:*J\`'AH#(BJ
MH7@)MA^P0`/#Q\0]&@#JJ?%ZB^S0!U5/B]1?9H`%50-@$VPCX;@4-_V<..@-
M2N&0Z1CR.&8O]WJ-'BB@)AD;A8X:M,1`-]]G4P[9I&'AX`.XZ`:Q(>9'V&Q;
MX8Y]W>X#1=E/TS(AD*"5W-_\JR"ZR(EW_>`PET`I5-[P.UF_F#^C^Y7!EB.H
M)>FTC,G4Y1X(&`0*4&JDLF[,8Q@W_EZ`7EA/1,N3JP\S%2J7(4_4C9!D_)RF
M$Q2GYFJJH<AA*(`/AN&@,CU5/B]1?9H`ZJGQ>HOLT`=53XO47V:`3^>RMC^L
M7FE8WL%ZK,+?<C)S*M$IDG*,FMBN"%;:IO+"K7HY54CA^6(;KD.L)2B!2B/V
M:`4#JJ>._#]@>S0!U5/B]1?9H#[34.8X`([@._H#[!^[0$0_F`9%DI7(45C1
MLL9.%JT6QF7S9-0Q2/IR=24%N9V0-BG!E'$)TP'<`%81\=M>-/\`<6ZGYK);
MRM^E=D][,+8LBEG8QU'2OEC25BNXIRM1R)14UH=&=',#:0V3\[<M1\L_,UG^
M'E7EJOSHHRR`@%YA9%!NGS.A]XB0[;N=OS))"(@45^7B0@\3[;!Q\?/W&8J[
MW!=M9`YK[YJ(UD3$Y>>G97@CD355IJ;4N7-M&Z5=<*Y:NKX>7L2@N=,JA&S]
MHJZ;&4;)K`5ZW.GRB=HH;IO4Q*8.<IQ1$VP#Q`P;#KH/8/3VPCNHKR6.5KV2
MM\]CN-*^)O#5%3MX&(Y;)3-B>V!Z.?RKP%><8J-#SP0YDC*E3?,4VJP)_P#W
M[!VLBX8NBB;<HE6:'*/#CN([^&M[MZ2PXK<?D-A1Z/N8G1^%4\QKE7X:_JZ5
M]YB;]SOGQS61U5[D=5:_#R]YE[;C%1Q>)R`8-BF=NK*^8LTQ]SG46=""(`/A
ML!#\X^@I0'5XW7TD_'=0;_"VMNBW#\K<55$JC8VO=XU3C14*>TW`S^6LN9*_
MNT5=?9JHD5]IC5*5<MF*1#,(X1BV9P*)0528\R0N.(CN=VN!U1WVX'#Q'6B.
MIG3NWL[R6"RY9?)=Y2-:Q>:1_>W71.SM,NQ67<R%KVJB))1:<:"`6.J.8@2B
MX)TG*G*L#<P_JHMSCNF=<O`4S*@.Y"CQY>([<`'G#<NW)]M,3S8TBOG,5RL6
MJJQ*5H[6GBX<.TS#'7:S2HJ*J+15K731*C@^R[(4A3\S1E9ZZGT._E/`2#05
M3`A]5307=PS]-(=R?,I*-SHB/#F(KMZ-=7^A?J+D=E]8[?:T4CGX7-*R&2&M
M&-D<M$?1:\.;@A@W5O%QYG`2WCFM2ZMV<_-3BG:GT(3:Z]WEXG+:<`U`B&@.
M!$"@)A$I0*`F,8X@!"E*&XF.(\`(4`W$1X`&@*''=/YB4M,^;*R[K:Q(KN:1
M@;)D)0Z0FDLHHB_QA3G;RN7HJ``?;Y:YHOY=T<O@H*Z7`1`NT*D_R%[]2]K"
M3479(6'L4([2D(6?BHZ;AWZ!@.@]BI5FB^CG:)PX'2<,UR'*/I`=1)*I1:&3
MT('`\0$-Q#?T@(@/VAQ#80XAH"*7N6\FKLP[FK/=<BS$'=J!EJ]R#J<E\AT2
M[3C1PO97:!$3S#NMR;F1K;L#*)$,=$J")3``\HD$=]`4>,ZUJ]X$R_ES"LC>
M;'*/<57NU4IX^96&>9M)K^F9!PU0DDV0OC))$?I(D5`I@,"9S;!S<N^E2>D"
MJE:EL[MA\AGM#D<-XVMV=7^4\I9%M],KEJLC@<@S-<KC%[8XAI,GB(>-A%&[
M@[**!]\N559PJ=?I\YMA'8!)<E%H)3WB>1O7L28WM6;.PK).8L>Y(Q[%/;:.
M/%,A3KMI;(V$0/(2#.M6%JZC;##V-%JBHLU257=-W:A>B8I><#`(#=/*L\Z?
M*R>3:3V[]W5J/D&D7V4CZI2<P3Z:*5TI]GEED&L!&7*1(4B=CK<T^43:?.N2
M%>LUU4S***$Y@*!;V'Q,''@(A[P;".PB!A`-QX`(>/IT!T+.$&R2Z[M1-NV;
MIG5<+N#@@V30(DHLLJHNKR)D211()CG$0(0.(CPT!5@\P;ST;6\M[[M\[`6Z
M<K(?5B5)[G!")_J!].6%=R$8A`X7KJJ+IH]%9\?Y=*5<I*_-+!_I4A()5Q`5
M7M3\D.5RF6.SCYFV2,@9BR98DT)H,1O[I,/&%<3<E3<$976T_,&D)*7*`[K,
M8I1DQ;#^D)U@#@!+E&^6KV!Q$-]`8=H6"`C3)BB<KJB1;]Z=,WYA/+/R.Y51
M4?C,L)_OT!&KWB>0!VTY0KDS9>UQNG@/*;5HZ=1-?^:=2N*;&[Y>H6)D(J24
M>255%ZH7D*\CURD1$VYD#E`0T`P'R"V-TP;WW]QG;UDZ%F:C=4<1/8Z;J4HN
M;FB[!1;K`NG(((BHJT6;.XZ=451<([I.VYRJIB)#E$0+@WCQT`:`YV$=]@$1
M]`!Z?NW]'#0%$GS%._J<G_-,9YYHLJH[K/:1>ZY3<<%:KG4924=0)HZF1E4@
M*`%6:V^8=2C940#]9J1(!W`H:`O'4FWP>0*;5+W6'1'U:N=;@K777B8@)',+
M88MM*QZ@"`B7F,V=%W#Q`>`\>&@-GT!V)?S"_C_".@(2>\9L1UW,7!(3$)O&
M4\#&.;D(`C6XP2"<_P"Z4!`./HUX&^N.ESZH\Q:(]&.6TQZ57AK8PG572].3
M95O)_CF_BN,!4J6[:@@Y>LG22*A0,B[+SBW,;<#$7;O2EZ(F(/$@<P&`>.L0
MZ9;`R%I;LN)K:9$\Y'-F1JT6JI1&K^7V$V_S#6S2PJY*JG?P'J4VFL+\Q$$N
M@RNS%+F4W%1%E9V9$P*19<NW,UF&X``*'#W%>!A](Z]#=H;-Q?4"SAMK1C+3
M=<3%JJI1EQ&Q/$B=[^_WH:KR^2O<3/YSZNLGKQUTJNNO=^06%W'5UG'T-:TR
M36&LE>!%J\C5BK+OG49'N#&;E^4:I+.!6`A2@F8P`!B#]FMU3VNV;"#!2[ME
M@@W-CWJCK=51)7LTHY6\:)3BO>8Q%)?M6Z=9QOEM7_"YJ51*\:*9YO&0#Z=M
M=PB719*6?,7`PD85,[9ZDY>-"HN'"2;LI.9?F((DY>(@80\=7YN(VM+G<EO3
M`S1S9NZB<R.*J*[G?2JHG>A2237D#8K61%2!E$5>S00^?H;2DQI).<31>V:1
M(92(AS?JMHL.0-Y:3*8/]0LW`-T4#!T^K^8>&M";EV!:;`Q<V9S7E7.Z)ZNC
MB758T?JKGIWM<NADMAF9IID9"O[!BT5WYD_.OT#,[?5W\JH[=D0=2"PBHHY=
M$2.8H'.(F,HNY`O22$3<=CB`>'#@&N`NHNQK[+/ER=M')-+*]%F5&U1$5=$;
MPT3M]E3<&(RMHV)*R-1Z-72NO`T;"#+Z9W`8G+SI&,%XB.H=)0%2@;JK%Z8J
M%_3,8`$=^7AQUB'IUM9<7ZCMLQO56/7/0,1%T54YX_TE=NUT<^T;Y_,E/PJ_
MD4GT'Q']HZ_1F<AG&@#0$<GFK=SZO:IV5Y8N42ZZ5^N[)/$^+FR0@#US<KX@
MO%D=LR@<%NK"1`NGA3%#@H@7[="+='(OM*D?F,>7XMV8XN[+K2+-47&4,,)1
MF5W:YU%0+FA@8]JENN4_,5`YZ]946A"^`_2C&#<1$=0H5:2-55U3B6=?(_[C
M#9Y[%J56Y1Z+JWX!?N</6`5E3*.EHB'11D*/(J"<3*"1Q5WB+<##P,=H?;42
ME?17JJ<*DP6A\AH#Z)^<O_,7_,-`>;OYDIC!WV]Y8@8=PSOD`-Q'<=@DBB`;
MCN(E`0X!X!J"E<SX4]R'H<82_P#1C$'_`+6X]V^[_P`(P_A]FHE&_P"+Y=XI
MADDUP%)4A5$U/<4(<"F(=(X"51,Y3`('(J4>40'@)1'0^3RZ+^D2.RC?&]8$
M_)'90N"-9%GP<<K:Z2I8,6G1V,#CE13Z8$X@8`VXZ`]/2F*R2U/J:DUS!-*5
MBOJS!5.;K!+*138\EU@'@"@.S&W].^^^@*_OG]][\UAW%M=[4\;S*T9=<WQC
MV9R+)QZZB,A"8C;+*1GT9-9,Q#H*WN8*=LH8H@86#5P4-P4T/I&N75$T&;?V
M\_9?#72W6[O+N\.@^B\8R2N/<,,W;<AV@755B1Q;;BDFJ0Q2.:W#OD&#$0#9
M)1XL<!`Q`$!!6JWBE"W@`<H<H>@.7QW'E`=]N;TAO^&A`-``@`AL/$/^_?0$
M?]U[*W$CYA6&N^6D3E=KJE;Q;=\7YEKSAB]-,9!CY5B*-+DXYRW#Y`LA!.#=
M-P=R/.=JBD0H^X&@)`/^/#;U>C0!H!C/F1=SR/:+V:YFS"V<IHVM.`/3\=I"
M;]1S?KD"D'7C(E*('.:+4<*/S@'$4FAM`4[N_+R_I7M4[8.QS,$@V>EL66*1
M+-LVN7"BCA9')]B<JY#KX/S*^\V<#49A2/,0-A%:,$1W,(Z`L>^0EW%_[Q]E
M#?&,N_\`F;;VW65UCQP117J.5*/*$/8Z"\5,<XG,1NQ>.8XH[;;1_`?L`FZ\
M>(:`[$OYA?Q_A'0$,'=HW%;N7N8\H[#'TX@&`AC[G"LQIN4``/'E#TZ\%O6O
M'<7OJGS%I`K^9+;&Z-;7C8PJ=1]-)T9LRW23]VCIOXCC;<5N)Z)!L>&%X0!Y
M>HT!K\TQ<@8?>*[CEBK,UP-]O+S!X[ZV;T>_JS`LB=8MNWL>Q.:-8E<V1&>+
MEX^'WZEMW"N+O'/AYT8]477@.WE;+%5*C3V0%Z.2!GZ^R24C739NNQBWTJ_=
MHQ[(`1.<G@Z<%.JERF+RAPWWUVAE]S8O:G3:YZA7."7';HL(G);OJB(Z>1/`
MJI1-%<FJ&JX(I+O),Q$<WGVSY$1W:K6KQI^D1W'*JLT[^K3#PS^3?N/FGKMR
M<557*ZPBHJ;F.(F(F!C^Z3<2D#@78``-:/Z=W-QNK)+D\E<+(VY7GED>M>55
MU5K:F1YF),7:?AK71$T'<%CH<L21R10$ET0YR"0_*9)4H%$#I''<R:A1#AMP
M^[77L6)P..P7GXR2ES&B/;WT[*F").Z9>23XD3ZS795Q%R4(-B<59Q;)TJAH
MI4YB+.8]`\>!OEW;]!(>'42,41Y2CS&';@&K1G+O&Y?`MS;,8N8S,*<O+7PM
M7CKHM5[:=I"*!8;AK5D\N-==.*ZC,,HN[',`HC*$<,V9`$R$0A'K144W][<0
M28HIE)S@'[YN8XCXCKB/JUD]R;F8]E];7<-M&U4\AD*L8RG!.:M%IWTU-IX9
MV+AAJR3FFHO%:JNG>-UQ0TZ6>L4@40#EOL(0"<I@_.NL&X#R[</OXZY&Z'07
M-GZF]J)Y$B?_`$<'Q<?CC-@;BN[;^BKRG^U7\BD[H^(_M'7Z+%XG)!QJ`#<H
M"`"/B(</3MN`"(;\/=`=Q^[0%=3N]>$[Z/-X[:NT!E_U;$G:6V/F_,B)3BO'
M.[6DW8SB46](GS)F%)#Z/&\I_P`II!R3Q$=@'N^<IV\#W"=A>6$HN/!_<,2`
MTS/4")I"=V9Q2B+K6)BV,0.</J-0</D^0H#SFY0V'AL!7@_M^.XW_:WN[E\,
M3$BHWJW<933L&*2Y^1L7(E-2<3=66'F,8H+2L`$BT*(`!CJ&2)Z`T!=N$-A]
M'AN'$-Q#<=AV#B`"'VZ`XT!]$_.7_F+_`)AH#S=O,E`3=]O>8!0$3#GC(0``
M!N(F&0#E``W#?F/L'XZ@5S/A3W(>@EA&[TDV%L3F)<JHH1MC"@IN%$['#&31
M,E5(E,X*&^>_3Y3E$!`VP@(#J)1OJCM1B/F$>:7@'M;Q1;X6C9$K.1NX>QP;
M^!QOCRBS#6S2#*R3#=:.8SUG7A!?-X.+@G*Y5Q34/\VY4*1-)(PFW`?)"+Y2
M_D_9+R!D*F]SO=95I.F8TJ<PSNE)Q]:63B.N&4+<W=$D8N>LD&Z*5Y!TMF_$
MCL2NBE<22R9`!,J7,<X%QT0'83`&_'<?1Q-SF$?#B8R@_P"`_=H#SY_.+R2]
MR3YC/<@JZ7%=O29BNXPA2<QA391],KD:V<MD2"(E*4\L^>+'VVYU5!U`K(]&
M(6\?*$QZRQSY<_;%'MFY$'=HI;G(<RH381>2E[FI*PF=*"'B<6;M%/COL5,`
M]&VHDB;X_9\OTDD^A*#0!H`T`:`X$-P$!VX@(<?#\=N.V@*Z?F&/Q[U_,P[0
M_+^BC!)XXQ*^0S]W!M$C'%KNR;#,(Q,BHF8R`&;5ALBU*4X[E5GR[!S:`D3\
MUGMV-W*=BV;J5%,/F[=4H(N5:`FBD4'(6+&_6GF[)@0"^ZK+P23U@0H<3?,"
M7[-`5;_(=[C4L-=[4;C^4D"M:9W(5E7'CA,ZBA&QKK%B>QX^=B`B`%45<HNX
MY,3`!A^H`7COMH"]2```;!OL'#CX\.&X_>.@.U+^87\?X1T!#3W6/7+3N9N8
MMW2R!BQ]-,'15,0P'&M1@<P`40$!V#QUX,^M"_OK+U6YEUG-+$Y+;&ZL<K?_
M`$8.Y3I_I\UJ[$ME5$KSS?Q'&Z8OMEZ=*-(^#G;([='W!)DP=O%U!$FP@'2`
MQDR$`?$3AL`:W-T>W3U"GMX8<+>9":Y5C45?Q$C6L15XO\25:O"FICVX(L;$
MB2W4<=%5=5:FNG:.GOE9L]TQ/:ZE.6J/>6B28$<0$""S9P]^L1#AM+M6BZR1
MBG.Z>?*"B)1_*)PUU7U"VMNS>'1W*[9SF5L[K=L]N^6S@8J/>Z9C:Q-5:51>
M;1%[%,"PMS;8[<,-UY:1XUTJ(]Z-Y:,<M'*G?1-=.X9#C/('T\"LGO,U=M%O
MEGC=[S(N&CQO[CAFL0P<R:K<P<IBFV-N&_IUP)TKZB/Q\,FV,PY8+_'S<KX9
M46&3G315JM%>S3O7W&V,S@67<"Y#'JV6TXU74<H?*B(QQB`NER&(IM^H)=^'
M(!B@/*)_>$.`<1]&NKK7JFMW"D,4D3KQZJC6,5%65SN"(U/L]R<$[C`_Y!%(
MY;AZ(RFO"E1<*ZC8&U*0;1]C9P-I?N%9=2)>J-T'*J#Q(A634QW`B+=P*")3
M@.W$3;#K?V"QN=Q^QDM;#(V]GNNX599+:2D:U7X41::+RTIV>TQ+(NLY<BU'
M,<L3&\M6\.*U543CW=^@U7*5IR''**LYV;LC)82@/2<NG"1%"\VP'2%$Y6RR
M1A\#%`P#Z-<@]8-T=3,?;28S.7N2B_PK<2.C=1=%8O,J(G=0V+MZ#%O8GDL@
M5>5?LIS<->ROO&V8NE73WN`Q05P]<N-[Y#<X+**FYC`N?B//^8?'CKDGHID+
M^Z]2FTW7,TLCEW%!7F<J_;C[U,_W3!"W9EYRL:G^E7L3N4G.'Q'7Z&5XG)8:
M@!+<WY:K.!\/9+S-<5TT*WC.FSEPD^H?I?,EAF2KEI'HJ#P!U)O@2;)!^\HJ
M`>G0%57RT*OYG<RXS1WR]OV,^W6WR'=/;IT\W9\[V:P1DZ5.&LTFZD&%=8P[
MIOTX`9EV*0*'.;J"P(4"@5,NX$J;^R>>G+,'T5)80[`WD=)LW4?(,W5TO1V[
MIB];J-W;98@2)P.DY04,F8!#80/QW#AH"GA=:OEOL7[JPC['',ZSEO`&2X"V
MECH%\N_ADGC%U'VR+:PLDJ5-:1@I*(<IHHJ&#<Z*G*8-P$-`>CKB7),!F3&&
M/LL55=-S7,D4VNW2'434!0"M+#%MY$&RGI*X9G7%)4/0<@AP$!T`H>@/HGYR
M_P#,7_,-`>;UYD!Q3[\.\I0I^F),\9#,!@`1'?Y\`#8H"7F'<>`;A^W4"N9\
M*>Y"SU:_(C[/LN]N=:D,3QMDPYF"=QK6+!#6UI<;-,5IS:)"L1TETK1599_(
ML7$))2#@Q'`-0071*<3I&W*4@Q*2155U5^6I5SP7D')/EX=X4+:)ZBL37?!5
M[DJOD7'\W&L7:4K').%8JT1;)9ZU630>OXE<SB)E"``D$6RR8@0P[CX/1-Q#
MEBCYRQG2,NXXFDIVEY"KS"RP$B0P`J9F]()C-7B/,8S60BW(';.4AXHN$CD'
MB&@%)#8!W']T0$`^T0'?0'G>>:_3WM-\Q;NSBWJ:B!IG(I;FQ.J0>4["X5Z!
MGF;@ACAN5(#OU.)>`B`#XZ@5L?P)[BYSY4EL8W/R[.TR58*)G(PQ3'55X0AP
M.9O*TV0DJO)H*[<2J%=10CRCX`/V:B4\OQ>W_@2$Z$H-`&@#0!H#2<CY`K6*
M*#=LFW!Z1A5J!59RX6)V=0"@C%P$<YDG'*)_<!58C42)E#BH<P``<=`5*_+F
MCO,IRCD7N#\PWMUQG@&VR/<1<[-6GDUG:QS42]B649--Y5[$TQA$+(*)PK8H
ML8]18YQ(H,8"92ATS"($M"MP\]Q5%5!7"O8,L@LF=)9%>Z7@[=9(Y3$4173"
M2V.BH0PE,'I*(Z`IVY\QKF;LS[H9^OW&$A:/E[&ETK^28MC4'J\C6XUP^?-+
MY5#U>35_7=UYJ*I$$>H4#E21.D8>8HB('HI]ON8H+N#P?BC-E;.F:)R=1:];
MDDDC"<C)W)QZ:DM%F,._ZL3*D7;']('2$-`+*E_,+^/\(Z`A+[QW*;?N7N"B
MJ95"DC*@!2"8Z7.8:U&B'.=(Q5-M_L'?7@3ZX9FQ^J/-OCUN&P8Q*+PY5L8*
MK\QU+TX8V78MLQ%7FYYOXKC\M'OTLDU)'MGYXMD8@%68Q8BP17(`@/\`J3H&
M*Y='$?2H<VXZD=..I5Q96C[*"5]NYZMB1(J\\O#PK7N5:Z4/C.8B%[$27Q.J
MNB]FG8/,HE@C*,W2GI5))Y9W;<30<.<R9AC&:NPC+S"HE`&ZS@?Y*8?JF('B
M&^^N^=AY[`[#MXMQ91K9MVR6ZI#&Y[GM:JUY7R555:M5[*&J<W:37+VVC6\M
MLU=53BOL_2OS=YE+;BO%600J]CM;)Y$7FY'3.ZEZFX2A7BC59R+=N]E69TEF
M+X2[%3*<Z0J&*/`>&JOJ)TCZ2=3K?$Y;>$*VF^LO)X+BW1L3V-T^)K>5KM5T
M5Z*JDC%;@SF)C?;6Z\]E'IROJJ+IPJBU0R=2P[C*FSMC80XRLS;:VR,]AW-G
M>(OVIG39#YA55I%HI-V(+MC"`>^0PB/O!X:N6QNC'2_9&3R&.Q+Y[_=./96&
M2Y5*H^)?%1K:-[/U25DMQ93*MB1T;(;:141>3FJB+HFJJ8JV6B-R$P3$J*#"
MZL4>5)N(E30LK0A3'^69*F-TPED2;G22-MS<2E'P#5OW=NW'=2+/\1<,9!NV
MV:K45KG1I(D:T75%1?,14HU$T5"JMK)^+NEBC;YMD]457.35%^;L_.,VN-XE
M4&JS$SY1RQ`1*,7)`#QDF?FY3B1LYW^66*.X"9/IFW#7"75'J-N%&/Q=W<.N
M8(UY?+EU?'1=*N^*E>&NO:;1Q.*M'\MQ!&C7*E.9*Z5T7V?2)IA9TD\S]B<R
M"14A&]Q`](ASF3`>JJ;],%#',F3CX;C^W6LO3S?-O_47M.61.5_]0P*J)PHC
MXZJ9)NZ-L6RKU7*M4B5OS477ZR?$?$?VC_GK]&*\3D`XX>GP]/[-`5V?[@#.
MLXYQ_A+LCQNHH[R)W(WN$?3$4S,8SE6L1<VVBJM&*IIFYC)6.\NT#@42B!DH
MY3?AH";_`+=L,07;Q@K$N$*Z1,(K&-%@:J10@<'TBR9)C-2R@B`&.O+S"CAR
M<QN(J*B8>.@%GT!4%_N/>W,('+.&>YV'8B5ADB`<8ONSI$I@(6U4P/JM5</#
ME#8JTK6GKA!,1]X?IQ0#P#0$@G]OCW(?[F]IMAP7,OBK63MWMR[&-;JG`%2X
M\O!GU@K_`$B";G4;1<^219<P!RD*1,/`0T!/MQ](;#Z0\=A](;^G;0'T3\Y?
M^8O^8:`\W7S)O_[L[S/_`'XR#_\`L2Z@5S/A3W(>AUA+_P!&,0\-_P#RMQ[P
M^W_PC#\-1*-_'Y=Y7,_N!.Q7Z["QW?'C2%YI:M-XVJ9\8,$#F6>U@%THZJY'
M,FD4W6<UA90L>^5'WA8J('$0*@)@$8VH]U%6@U?R&>_XF),C#V=Y1FQ;8SRS
M-*/\024@N/RE-R@[`BCNJ%<*FY6\-D7E`S</=32EDBAP%R;4"8Z%$2J*I<J$
M!`>(;;`7<.8!,!MMS`(`'AX;"`CN`ZB2"IO_`'%O:A)M['COO*JT8=S!O(AC
MB3+RC-`ZAXJ0;.%E\=V20%(#?Z*00>N8Q10P`4BJ;8IC>\70FME5J<J(;[_;
MJ]V44K5LB=F5IE46]AAY>0RIB1!T<B/U>"E4VY;[76(**<YWD%*I)R()EYC'
M;O%E`#9(^A\O?SZJFI:*^S]@?Y?=OH?`:`-`,&\Q+O;9]CN$XVZ1<#%W;*N0
M+G7L=X?Q[*/W+!O:K1,R#9)\L]58E._3AX*,5%9PHD&X*'13WYE0T`^Z/,^4
M8,5)-%%M(J,FJC]NW,91N@^,W1,\205./.9!%R8Y"".XB!>.@("/[@7N-DZ=
MV]4+M5HQUW60>Z&XQT:^BV*H"]7H%>E8TZT?TB;K@%KM[J.8DV#91,BY1].@
M)<.T#`T?VQ=L^%<$1Z:1#X[H,-&3:J`$!-_;'B0RMODQ,7BH9_97KI0##Q$#
M:`<EOMQ^SCX\NVW'?F_=V^WT:`J@_P!R!V\&:36!NZ>%8\B$FV>83OCM!(Q2
M_.-"O;3CZ0>G*/O`JW4E&H&-P`"$)Z2Z$R-B/K4<K_;J=Q87/MYR1VVS+TIY
MO"5I+9JLV5/NL-`R,J[?*H-";B(M8.XM'I#B'NE^;)Z!#1#Z?&C4JA8M2_F%
M_'^$="20Z]_5->PV7&-RZ)QBKA!,D2N.7=():OMP9.&O,'$JAF`H*@`^)2"(
M>`Z\3O[B&P\C@NJUOU&2*F)RD,,;I:I1'PPI"B._5^!**IT?TBR=O-C6XQ[O
MVD3GK3V.<KD7ZU3YAI=7L0P[M-T!3*.40W;\VQD$UOW5E4S^ZJ*/B4H^Z)N(
M^`:XAVUN3^FL@ERGEOEXQJKD\+U75W'5.6E%X&R,E9K<2+R41J?K>'ZE%]JU
MN4E9%JDZ>B9:0<))N'2YQ44(!S%*NX5,([B""0B;CL'*'@`<-=);"ZD?S7)L
MLLA<))/+(U'2N7@BK\")V(8=D,/%Y3T3D63E6FJ<1<7F422]A;229RHM6SM@
MRB&XB;=K%QBR:;,F_P"Z84T><PAXG,8=='Y?JO;[CSL>0?(V-L-S"RW1%T8U
MBKS43LYM/H,93;[8,9(UW)Y[JKQ355,A9<GJQF0YJPL52&69V.05(01-R.$$
MG"B8ME-AXHN6IC$,'H`?NU<MU=6DM^H^0S^,?R?ZZ9$3L=&YZUK\W84L.W6.
MQT<;D;YB0M3XD^*G?PX]HCE\M[9E*/RQJR@,E%0D8M4AP*HD@Z(5PTYA`0,*
MR!#\AMO!0@[:YYZC]3VV&:\S%R(UCD5\2(O*Y5<M7OY>/A>JMIV\3)L1B/-M
MF0W*,\Q/BU3C737W#<K;;EIA3K+B)WRFQ'+@H"`/-AV(L8H!L5V(<%#<`5V`
M1V$./,.[=W7.?O63SI)_,G2QH]4:M9DYDUIV<J:^VAG^.Q;;=&Q0<JP\5U2N
MFO`5[M`I<A;LZUF1015484M1:TS#@"B*;<&Z*S:,3`X@!>JZD5BB4./,!!$.
M`#KH?T5;%OMT]=L9E((726F(E=+<.[(G51657VT^8Q+JED[;&[2N+:9R)<2Z
M,;]I>_1.Y-2<[T<?Q_X^\=>_/NX'*"<!G?<CW]]I':@VF4<SYMID!:H9@5\;
M'D=)H3>27AG#8'+!HSI\:9U*D6D4C%.B9=-)$Q#`83`3WM")3MI/F"T+-/FR
MXX[S.Y`ZT!BF'O::==BC#]8)C>HPU?EXG'3AXW9D747"%G7B,E)';IG,+E15
M0@"``.@+MV(.XS`O<`S>O\(YAQ[E9O%H,EY<:1:(N?<0Z<B"OR)IEFQ7.\BA
M>&04!,'":9C"0P;;@.@%B7<-VJ*SATNBV;-T%G+EPX4(B@W;-R"HNX754$I$
MD44PW,81`"AQ'AH"N5YVW>5V391[.;-B.M9PQ[DS++FYTF?H,'0)MC;58F5@
MIM():7DI2'%W&Q3%.MN'J!Q47*<YE"D(`CP`"NQY<O?1(=B7<2PRB5LI9<?V
M*,/2\K5)@]03>S-4=N4G2$C%<ZI4C3M9?H@Y:E4$I%2BHD)B@IOH"\_V[=_G
M:!W4?1V.%<[4FRVF88F>-Z`^D/H&0TN@V,Z>-UZ=-_*31W#!!,QENB18A2%$
MW.)-C"!BL\>8OV4=MR]@C,J]PU!BK;5SK)2U"AY,;->T7S=(J@Q!ZM`@]DVL
MHJ58H%3<`AMS%$Q@+H#SYNYW+\;GS/\`G;,L>B$.RRMDVY72*BG[EN=TPCYN
M5=+Q39[TS*@#Q&/*D"P$W]\1`/`1U`JDE8B4+MO93YM_8_E#"N+(*S9RI.)L
ME0-+JE5M%(R5*$J*S6=@X-E%.E8N8E@;P<K%OEF8JMU$G(B"9P*<"G`0U$IW
MJBNTX$K]A@:O?JI-UB?CHRTU&YUYW#S48X*D[BYVN6!@JU=-U1`>DX92$>X,
M`"41`2FW`?`=`U:+7@>=SY@G:%9>P[N@L^+@=RJ-36=EOF$KD"JK=])TAW(*
M.8-9O(EY-K'3'R(L7)RB4Y7#8JW`%"F&!/65BM]M"R3Y?GGM=OE]QO5L?]W5
MW1Q1F>N1;2%DKO.MW*]$R($<V*W0L8S,8D\)79Q\BF47K=XFBB9P8QTE#%,)
M2Q*8FP.ZP#W>X:L,3'S-&S?AG(T7*UB<5@)AA8:S-(%*"#]@62BUEBMY6-6Y
M#`)3$7:K`0X<IR@(`4YN\/RN.ZSRZ,L1_<'VQ+V^^XOI<^-OHN1J@S4E;[BP
M[5511")R%7HY#YA]$-F:@M5Y%,BK%^S.8KA-,QQ(($X'8EYX7;AW%0</4<_S
M\#@#.#9%!C))6)W].QO;Y`"E3-)5>SNSBSA%'HE$ZD9)G17;*;D(HJ&PB!,X
MTR'C]_'DEF-\I;V*53!9.3:6J"<QZB!@W!<CU%^=L=$0X\P&VVT`Q/NG\U+L
MM[6(*4/9<N5V_P!Z;(*FBL78OE6%OMLJ_3()DFCI6+<+Q%;1,H``HXD'"!$P
MX[',`$$"K5C+N.RCYIOFJ=LD_DM(B54C,H14A4<?1"RKVM8^QU0U'E]?,@<F
M+T7<Q*J5],9&06`JSM82E*4B2:9"@7`>XGOC[4>UE"2_WQS?1Z9.,8U.5"EG
MDT92_/V3LJAV0QE-C!=3SD9'IF!N?HE3,/'F`..@*9UD\PND=QOFG8@[N<W)
M/(;!-$R756E;KRQ?K#BE8VJ:CY>NOY2-0(X%P_5LZY)>4*@"@B<YDR`8$RZ`
MNW8:[F^WGN)0>.L&9GQSE3Y%FWD9)M3;-'2TG&,7:@HMG4M$HJ_4XM)94HD+
M\PDG[X<OB&V@%P.8I"'.<Q2D(4QSF,(%*4A"B8YC&,(%*4I0$1$>`!H"OMYR
M_>GV07_LHRKAZ,SKCK(N5)QY67..JO0IQA<)%C;Z[:(U_P#6'[B*,[CH6/C(
MUL[*NNX63#E.)"@83;:$R-R-6J\"L/V"=Z,UV-]QU7S;#('L5;59/*IDNGM'
M[9HM;*+-&;J/6[!=4Q$$9B&>M$7T<*NZ9ET0(<0*<PZ@3'R,<U43B7K^VOS$
MNS?NI/`,</YUITK;[`@<[7'$V^)6LBI.T6J[Q['&J<N+=\]>1[5`YE1:?,I]
M-,QP.)`WU$IQR&5\857+58?U*UMSJ,UP*X9OFW(1_#2*1!^6DX]<Q3=)PCZ2
MCN10NY3`(#K5_5CI3M/K#M6XV?NV%TEI,VK)$1*PN3@YJT[]53M+CA=P7NW,
MFW(8]W[1BIS(O!4[E3VD1&0>S3,U,D'7]/1(W^#YU#L9"NF0)*&;\VZ97T*[
M5171<$)L!ND94IAXAMX:\;.I_HCZO[+OU;M/'29O;[7*V!UNU72M:FM9$3FT
MIHG#4Z2Q75+`YEB7%](VVFY41>;X55.Y=$K\J"=,L.9WC%#"GBN]=7I*(F$8
M%Z(@58O*?E`O@<4AY>&_`=:LL?3_`.HO'M\R+:.91[EI5L3J_-X.)?/ZHVA-
M&JNOK:M.]/O&PML7YU)TN;%E\+L<@\(%^`E(41\/TAV\=5]OT-]1F.GB\[:N
MXEI(C_W3ON'Q=;@V<MK1+^U5:=Z?>/U2>-LZNG3UQ_M;?=W#A=<3#`O]]UC"
M)AXIA]O#5QR71OU,7F0GNX]I[A\N25SD_9.X*M?\LIX=P;/2)J?C[7@G=]XU
MM]A_/#XJ)`Q9?#BB04R;P3[8""H90"B/(?<"F..W[=6#(^GWU*Y&/S)=J;B3
METTMW.777CR:?05#=T;0@:JMO[;Z4^\;/2NT/.MR>)HO*PK3H]14A',Q;3`Q
M230./ZAD(])121>'Y=R@7D3`1\3`''6;;`]%G7K==]#;Y;'7&)Q\CO'/<M5)
M8T[T14:6S)=3MLXJW=-%<QS24\+6\5<NB:UHFO>2V84PM6,*U8T#!=9Z_?+%
M=3TZ[*0KV7>D(*:9CD3,8C9FT(82H(E'E3)Q'<PB(^RW0[H;M;HCM=,#@4;-
MD941UU=.;XYW^_L1.%#G7<FY,AG\@Z]OG>+7D972G<+-]H?:&VMT\"P#=;=V
MA]K&0+Q)Y+O?;QARYY`FBLBRUPM-`KD]/2)8UJFR8%>/Y-BY67!FT1(DGS;\
MI"@'HT!R\[0>TY^W,T>=L>`%VYRB0Z1\04(`.4Q1*(")8$I@W`?0(:`V+$_;
MG@3!#FP/,+8=QSBQU:P8A95Z)5(BMJSH197!8TLH>,;(&=D8%=*](IMRDZAM
M@XZ`5YXS:R#5RQ?-T7;)ZW79O&C@A56[IHZ2,@Y;.$3@)%4%T3B4Y1#B41#P
M$=`-4A^PKLD@!(,3VF=O;02"`D'_`&IIZXAL?J%#=S%K"(%/Q`/`/1H#<5^T
MKM4<I'17[9L`*I*)BD<AL04'8R8_NCM`AL&@/QTGL][5,:W.*R+CSMWP]1[Y
M!DD$X>VU:AU^$GHPDJT.PD@9/V+)%5`7C%0R)Q#B*1A+^4=M`8^Q=D_:#;[=
M.WZV=L^$[/=;/)'F;%:)_'E<EYJ:EE$TTE9*1>OF*ZCEXLFB4#G-[QN4-]`9
MQ+M*[54$DT$>V?`)$D@`$R!B"@"!0#AL`F@!-Q_;OH#3IKL)[)+"90\QVF]O
MCPRP@*IO]JZ@W$^Q@,',+6,1W]X-`.K9LVD<T:L&#=%HR9((M6;1N0J:#5JW
M2(@W;-TR@!4D$$4BD(0NQ2E*``&P:`2G*';]@W-KF`>9BQ%CO*#FJ_._TVM>
MZE#692#"2^7%^6--*M'`MB/!:)"H4/=,)`';AH#3'_9KVC2;$L:_[7\`.F)`
MY2MSXDHQ2`7;EY-TX0AQ+MX@(COZ=`*CC+$V,<+U<E)Q)0*GC>H)R+^7)6J9
M",H"&)*2JI5Y*0!A'I(M_G'JI`%0^W,;E`!X!H!0!#?TF#]AA#_'80`P?<.X
M#Z0T`RW,_ET]D'<$[=RF5>VK&,[./@-\U8HR%_I2PN%#"8PK.9BJJPSQXL)C
M"(F6,H(B.X\=`-2+Y%/EO)K@=+%-T09`H*@PR.7LBIPY@'Q3.S+.@)DONYM`
M+WCGRJ?+SQ:HW<5;M4Q@X>MS"<K^UL'MV='4$0,*J@VM]+H'4W#\W)OH!ZM:
MQYC^EHHMJ=1*94F[8O(V0K-7@X%)N3E$@D0)%L6H)%,0=AVVX:`2J]=I7;!E
M"YKY%R5V_P"(K]?'3..CW-MM]$KT_.N&,0FJE%-%W\BQ755;QR2QBHE-N!"C
ML'#0'R[[1.U!^W.U>=LF`'#=0G343/B&A[&((;<HB$$!MOQT!E\4]L_;U@N5
MG9W#&%<9XMF+.R91MAD:)3X:M.IB/CEE7#%D^4BVK<5FS5=8QRD_+SCN(;[:
M`6U0A%4SI*%`Z:I#IJ$,`"4Y#E$AR&`>`E,41`0](:`:9'=A'9'$KF<Q_:;V
M^H+F76='5'%E16.=PX4,JLJ<5XQ7F,<YA'CX;\-M`;HIVE=JBR)T%>V;`!TE
M$^F<AL/T#8Q-@#E':`#AL&@/PT_LV[3:'=X/(E([<,,5"]5M=TY@+;6L?UV%
MGH=P\8.HUTNPD(]B@NW57CGBJ!C%$!%)0Q?`1#0#E5OS_@&@.K0'.X_:/^(Z
M`-Q^T?\`'0!N/VC_`(CH`W'[1_Q'0'`\?'C^W0!H`T!TN5A;-W#@$'#D6[=9
M<&[5,%7*XHE$_0;)F.F51RIML0HF*`B/B&@&N8R[D'.6LJ3-&KE&E(:#J#&1
M<6V6M*GRTNU>HN%(YE'H1;07+9LLY?%.`@=<X\B1A`N@'4\O+L7<!V`.(;AO
MPWW'<1'?[?OT!HF2\@0V+*3-WR?0D'49`HHG6;1:(+O'"CIRDT;HI%,HDFF)
MW"Q=U#F`J9=Q'0'UC:^P^3Z1`WJ`;OFD5/MU5V[:12(D\;G0=+M'"*Q4U%4S
M"FX0-L<AC$.40,`[#H#>=`&@.-PY@+Z1X[CX?XZ`Y_`0X[?B'$?\/M\-`&@&
M[9][@F."XMJ\>4^R6!:2$48QRS*T:5]1Z*3@_P`@ZF%EE%4G?(@)A230,8Q-
M]C`.@%FI\A,2]4K<M8&#:*FY6%CI*4C&:BRK:/=OFR;E5FDHX_7/\OU>41-Q
MY@'0&QZ`-`&@#0!H`T`:`-`&@#0!H`T`:`[$OYA?Q_A'0'*WY_P#0'5H`T`:
M`-`&@#0!H`T!H>3[PUQO0+;=GH@"4!#+N6Q!,``XD3CT(YMQWVZS]=(HCL/`
M1T`P;MXR;C;`..C7')\TJE>\Q2[JWN(U@S5E9WZ`=RX2B'KIJW_49,'BHK.B
MF4$.<JH"4-`210LM'S\/&3D2Z*]BYABWDHUX!A$KEB[2*NV7,)BE,`G2,`F`
M0W`=]`(_E?.>'\=N&U7OT@5X[G.@T6KS:+&P'*U?G(5-2:9D3.V;L5=RCLIN
M8Q/>`-N.@%G8,F<>P:L(ULW8,&J!$F;9HBDU;-FQ2[I)H((I$211(3P*!```
M]&@$TM^9Z/3YYM4EEIBP7%VB+PE0J$*\LMA18`4#&>O64>42QK,I1Y@.X.F8
MP#P*(B&@-MI=UKF08%K9*I(I2<2Z,Y0ZP)+-W+9ZR4!)XP?-%P*LT?-%/=43
M.`"4?NVT!B,JWMEC;'UIM[U9LF>'AGSN.0=*D3^?E`1$D<S1(8P'7%5V<O,4
MH"/+OZ..@&@X#[JF2%6@&F<+-80M5QF'RL7.R=16BZJBR7<$;1;!I.-&+:/6
M;F$O.)]C@3J@`FV#?0#_`$AMP`P"!@'8Q1`2B!@$`$!`2"8!*._`?2''0$>_
M<PY2R3W!88P^9RV+!5\5+W<E5S@FR:LBBJ_<G=J',1%(C>"B5!%0YB@0'&X^
M(;@.'K_=#ABSWEGCR$L#I69DU5$89TK$O&L%*JD`W30BY1<I$G0.!2.")BDZ
M:O*(%,/#<!P?_P`-`:I:;Q4J0W0<VNP1T*FZ443:).CG,]>F3*!CE8L$`7?O
M11WW.*21P+Z=`:'CC.M%RM8[37J2::DTJFFU,^L1XWI5QV9VLJ@BE'/A."JR
MISH''8Z9-RD-MX:`VK(N3:9BJ`-8KK+$CF1C&29H)I*NY"4<E*4_RL;'-RJ.
M')R%,',(;`0!W,(:`2R>[K\*URJU6WR-B=BPN;-5_"1S6)>.9TS%LZ69.7SJ
M)3*"S%JW<MU"G45,!1%,>0#"&V@'!1<DQFHR.F(Q?YN/E6#:28.B$,!'#)ZF
M1=LMRF`IR"*1@]T=MA'CH!&FO<;B5_?E<;,K*"U@;-9%ZY>E:+_TTDC#M3OI
M-,UC/TXWF9M43F44`12`"CL.X:`Q]6[GL/7"YO*5"6)R>0;,'TB5^^BW4?`N
MFL8U^=?N&,N\*W260;LBF6YS@4IDR&,`B`:`_53.Y'%%_O"V/JO..WTZFV=N
MFZJD0^:14JFQ(0[L8E\Y(G\V!$S=0AN0"*I[F*)@#?0"\[;^&@-.M>0*71P9
MC;+'&PRCX%CLVJZJBKUV@@7F6<(1[5!P_600#<5%"DZ9"AN8P:`U+%N;*9F%
MU;4J465=Q]0D&\8YG'+(K>(E7#CYDQ1AW'744=)])N"@B8B>R:A!X[Z`5[0'
M8E_,+^/\(Z`Y6_/^`:`ZM`&@#0!H`T`:`-`&@(_^]F7F+<]QO@"I[.9R]S"4
MM)M=S],C%J<[>-^=$GY&?5!PY4#A[K7?T:`Z<Z8_JF,,'M,60$<WL>3<HR]?
MK<?(O&R3N?FY1%RQ5?2Q%1(HLPB(MBR*BDFGTT&Z(@7;B81`>Q1*S_1M%J50
MZPN3UNM1,(HN.QA678,4FZR@`(<HE%8IM@VVVVT!'[_1T)EGN;8X_A$5I*@8
M9>/;=?)AVY%Z\L]\?.^NZ^K2!R"J\6"1;H-$TQ]Q-JV4(0"E``$!]V5[RECG
M&]UO1D2J&K4$ZD&K=0.8BT@;]&-2.!=Q,D=ZHGS`'[HZ`:_VHQ"=2Q-:<\W9
MR9Y:;T$Y;YB:?;*N0K\29RHT;IN#>\BD]4;J*<@"`>\F4H;$+H#Y[#$Y)SC:
M[V!WUDHVSY#EY.+*H;9-,IFK8C]P@(_F(=X?E,(?O$V'PT!J/?"PC[--XIQ_
M%,DG=VO\^V9)/%%%7*T7!-714#FCVQS&;,`>O7)C++)D*HH1ORB;E``T!SWQ
MQ+",Q;B+&L"ASO7%I80E<8I%(5<4(J!4BRB@3D`P&4=.VX<!`HF,`CX:`?W!
MMSQD'#,7RNZ\;$1K-ZJ8Y>85&;!))=PH;<`*4QT#"(CX;;Z`C*PS3ENXS/66
M\FS0KJX[0EUX<[4BG*C9F[99LE$5@RFV_P!&%C&HKOBE$`73,5(=R*&T`IF3
MZXC<>\["]>@V;9%OCVJM;/.*-&Y$"QS!I)2#Y@BN1$A"()&Z***)1V`O6V`-
MAT`[++^38O$U'E+=(("^=%.C&P$.F<2+SMBD%`2BHA'E*8VSE;BH8`W*F41\
M=M`-YM<T7M_QE,Y>R.\:S^<[DU.@R46(1P6.EW[8PL:I66BFXQM9JB*PG=&2
M`@KBD8ZIC"8H:`W;M(QLMCO$$6O*H\EGO"Y[G853E`%S'E2@:+:J[`')\K&\
M@B3P*HH<0\=`)#WROHBMT\J[5!=U=\D*1]&:`=PHX.QJL8Z/,324&S.F8K%:
M8>':IN#(AU'0B0IC;%`-`*UAWMSJM>Q;'P%_KL-9YZ=CXQ>T$F6:,@DT,R`B
ML57VG5`1:L*]^4I4^7J+BHH;<QQ'0"\V>'AG5.EX5ZY7@*^2(40?.8AS]*4C
M8%FD0[Q!HX1+_I&_R*!B'$H`()&,`;#L(`1DX)HS/.&5[MF*=9I0F'ZH`Q45
M#E3*WC'4-!M4DXNNJDV3`T3'QC(CR1_,"RIP34$0$X"!]XOK2/<1FK(6=[>G
M]+Q)4?F6Z20E^59R\1#M3?389UR<H*QK6)0^:D4R\#`<B`[@)@T`L/:[&JY3
MRAD;N5E6!6C!V\4I>.&A2%(BWA6!$6:SA%-,A$P.A'-4FW-X`<ZI0]&@'-9L
MRJCBBG%E6[$)FSS\@TK5)KX*"4\U990_2:(J=,14*P:!^LY,'_TB[!Q$-`-V
MRG,,>W7%<O/33]*TYZR@T<1:TXY3(O).Y)\V.#M*&;&YAC*I54%SD;-4N5,Y
M@*)MSG$=`+AVU8R+BG$%9KJZ()3;]$;#9#B4@*GF9@I7*B*IB``?]/:"DW*7
MP*"?#0"\Z`[$OYA?Q_A'0'*WY_P#0'5H`T`:`-`&@#0!H#D!`.(@(@`#P#Q$
M=AV\/OT`R:^XSS'%]RR.9J16:_>8I2LHP#-C,V)""+"+"Q,P5<K&4256!)(Q
MU%0%%-8YRJF+[HCH!9:/B>01M:F4LG2C*SY+68C&QJ<:BJC5J)#J[&-#U1LO
M^J==7_\`(?*[+K#OL!"\-`*]/!+&@YHL$*/UTT3(EAA<G`B`2QF:Q8\RZAM^
M5,'8D$QA\`XCH!E_;1V_9$IL:H?)B[**46MBMP>Q4)(*NY:T3B1"$C7-LF6Z
MHH&BH=9155NR0$2N%3=5<1X$T`Z7*=$1R5CJW45=P#0UDAEV*+PQ3*$:O@,F
MY9.%2IF3,HDB]0()@`0$2[[?9H!KCG%6:;GC&DX'?Q<7CREPD?$Q-\N#2<9R
M[ZTL(CI_Z6J1;(.NQ;RJJ?55.[$ADQ,!1*8`,`@._JE4@Z168>IUAD1A"03!
M!A'-1$R@BDD("=1=0=CK.72@BHJ<=A.H81'0$>3!]:<I=W5JR-4H-O:H7"PH
M5IK%*RB46+LGR\C%+'AWCPOTXDBE(+.70`J8A#)D\=Q+L`YNOXKLUTR>US%E
MYO'LG-::J1V.,>L'A)9I5TEC=1Q.STH0A&LI9')A#E*B44&X`&QC"`;`*YDV
M/LLMCZX15*!I_5LI7I"+@SOW`M&Q7CYNHSZKAWTU1(""#DYBF$!]\/MT`VNO
MX\SCA;%F+JAA^'ILO,-)1V[R>G,O!00?+2)TU50CGRO25*R1VZ)UB%,L!$B"
M0HAOH!<,9XW6JKNS7*RN6LMD:^OTWUJE6J2P,&2#5(J$568$K@P."0$.V`"E
M.?8[A0!4.&X@!0$C[KL790R*3&#K&B,7(NJ;:C3SV-E7K=BT,Z(5H>-D5U')
M@37;-5&IRJ)EW4`B@[!N.@$?S1V[YQR+.8YLT@XK=TG4'HKVAB=^O`TVL-$G
M#!=E"P[!4RSUS"KE(N#]P7J/'*AB[!RE*``/CHE6=U>,>%EIAQ/V&9?FE[!*
MJ%4;LE)!1%-`C&#CC&.G%0,4V1(W:H%'<"$YCB8YC&$!#[CABR7_`+CJ9?;$
M6,4QKCN$!:"9B^45?2%G.H=WS.HP4>1)!N^435!03B!@;$+MZ-`.HWW]?H`.
M(CN(CMXB(^O0"&=Q-5R%>L82]+QP:+1E+,LVBY=Y)2!V)6M=444/(BU.""H+
M.794DT3)CRATE#[#OH#1KYANX1O;HTPSB`(E"1=,F$'-24@^^EIGCG0BO9Y$
MBB2"ASNI1R(E$NP"*9^7@`:`_'D/"]LB.V5+#V(D6:LJ9K$QDP8SA"+5EV*J
MP.K.Z177,DB#R5<EV'J&W%N(DW`=M`;O@S%,W0*]`C:';+ZM$UEI6HVO0*[D
M*Y7&7,D]E%""XV&9G9J4$5GCY4H`(E!-("IAQ`3WN4Q?EJYWK#5NQBVAI`:!
M)/I!9I/OT6<<TD3N&2C-^\1.8IG+?H-C)F!$#KEX<H`/'0"6Y2[<\TVO)^-[
MNHXK=Z>LE4)*T.IER,;5H9ZTDP=Q\-'0'4.]-6XU!,A]B<[A^MSBJ(<P<H#Y
MJ56EJK"_(.YB0L,F[>.Y>:FY(YNO)S$D<%7JZ#;F,C&1Y3`!&S1(>FW1*4H<
M0$1`V[0'8E_,+^/\(Z`[%$SF-N`;AL'I#_M'0'7TE/A]9?;H`Z2GP^LOMT`=
M)3X?67VZ`.DI\/K+[=`'24^'UE]N@#I*?#ZR^W0!TE/A]9?;H`Z2GP^LOMT`
M=)3X?67VZ`.DI\/K+[=`'24^'UE]N@#I*?#ZR^W0!TE/A]9?;H`Z2GP^LOMT
M`F>3Y^\0-?=IT*ARESL;YB]1CA;2$)'1T6\%,$VSJ26EI%HJ<A#J=0I42*";
MI[")=P'0""]GF/K?C>HV.#N])F(*V3-A?V"4GGCN$>QDN"R;=!FD@O'2SUX5
M5$HJF,FJD4O,81`W'0#QNDI\/K+[=`'24^'UE]N@#I*?#ZR^W0!TE/A]9?;H
M`Z2GP^LOMT`=)3X?67VZ`.DI\/K+[=`'24^'UE]N@#I*?#ZR^W0!TE/A]9?;
MH`Z2GP^LOMT`=)3X?67VZ`.DI\/K+[=`'24^'UE]N@#I*?#ZR^W0!TE/A]9?
;;H`Z2GP^LOMT!]IIG*<!$-@#?TA]@_?H#__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
